Brief: Liminal Biosciences Special Committee Of Board Of Directors Retains Independent Financial Advisor
08/05/2023 13:06
May 8 (Reuters) - Liminal BioSciences Inc LMNL.O :
* THE SPECIAL COMMITTEE OF THE BOARD OF DIRECTORS OF LIMINAL
BIOSCIENCES RETAINS AN INDEPENDENT FINANCIAL ADVISOR IN RESPONSE
TO UNSOLICITED NON-BINDING TRANSACTION PROPOSAL
* LIMINAL BIOSCIENCES INC: SPECIAL COMMITTEE WILL EVALUATE
PROPOSAL AND ALL VIABLE ALTERNATIVES THAT MAY BE AVAILABLE
* LIMINAL BIOSCIENCES INC: NO DECISIONS OR RECOMMENDATIONS
HAVE
BEEN MADE BY SPECIAL COMMITTEE REGARDING TRANSACTIONS THAT ARE
SUBJECT OF PROPOSAL
Source text for Eikon: ID:nPn4rpyKja
Further company coverage: LMNL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Liminal BioSciences
See all newsBrief: Liminal Biosciences Announces Completion Of The Plan Of Arrangement With Structured Alpha Lp
Brief: Liminal Biosciences Files Amended Schedule 13E-3 And Supplement To Management Information Circular
Brief: Liminal Biosciences Obtains Interim Order For Proposed Arrangement With Structured Alpha Lp
U.S. STOCKS ON THE MOVE-Liminal Biosciences, Tesla, Quad/Graphics
U.S. STOCKS ON THE MOVE-T2 Biosystems, GoodRx Holdings, ShiftPixy